How Big Pharma is fighting Biden’s program to lower seniors’ drug costs
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
A $100,000 gift from UH Mānoa alumnus and philanthropist businessman Jay H. Shidler will help the UH Cancer Center increase public awareness of its work.
Don’t miss the chance to get your questions about managing anemia with low-risk MDS answered in this roundtable webinar. Register now!
This JAMA Insights discusses the adverse effects of climate change on mental health and proposes solutions to help mitigate those effects.
The OncoAlert Newsletter is now out for June 23-29, 2023
Background: The COVID-19 pandemic disrupted the healthcare system, affecting physician wellbeing. The consequences of reduced time spent with patients at bedside during the pandemic has…
Jeff Bolle wanted to coach one more football season. He did and it was even sweeter than he could have imaged as his team won…
Date: April 30, 2024Presenters: Jean Connors, MD; Jori May, MD; Ashkan Shoamanesh, MD; Deborah Siegal, MD, MSc, FRCPC; Jerrold Levy, MD, FAHA, FCCMFor more i…
Join Dr. Lisa Zhang from Massachusetts General Hospital as she interviews leading pathology experts, Dr. Sarah Dry, Chair of Pathology at UCLA, and Dr. Laura…
C. Ola Landgren, MD, PhD, discussed the FDA’s unanimous ODAC vote supporting minimal residual disease as an accelerated approval end point in multiple myeloma and…
Ornge, Ontario’s provider of air ambulance and critical care transport services, and London Health Sciences Centre (LHSC) are pleased to announce the expansion of Ontario’s…